 RenovoRx RNXT stock is running higher on Tuesday following news that the U.S. Food and Drug Administration granted it new 501k clearance. The post RNXT Stock: The FDA News That Has Biotech Company RenovoRx Rocketing Higher Today appeared first on InvestorPlace. 